We are live on ! Find out more
MGNX icon

MacroGenics

119 hedge funds and large institutions have $638M invested in MacroGenics in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $770K

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

20% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 35

9% more capital invested

Capital invested by funds: $583M → $638M (+$55.4M)

5.54% more ownership

Funds ownership: 85.82%91.35% (+5.5%)

5% more funds holding

Funds holding: 113119 (+6)

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
20
Increased
42
Reduced
35
Closed
14
Calls
$1.21M
Puts
$770K
Net Calls
+$442K
Net Calls Change
+$218K

MGNX Hedge Fund Activity: Q4 2017 in Review

119 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2017, worth a combined $638M — up 9.5% from $583M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new MGNX positions and 14 closed out — a net gain of 6 holders — while 42 added to existing stakes and 35 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $21.3M. The largest seller was Fidelity Investments, cutting an estimated $14.3M.

  • 119 institutional investors held MacroGenics (MGNX) as of Q4 2017, up from 113 in Q3 2017.
  • Funds reported $638M of MacroGenics stock for Q4 2017, up 9.5% quarter-over-quarter.
  • 20 funds opened new MacroGenics positions in Q4 2017 and 14 closed out, a net change of +6 holders.
  • The largest MacroGenics buyer in Q4 2017 was EcoR1 Capital, an estimated $21.3M added.
  • The largest MacroGenics seller in Q4 2017 was Fidelity Investments, an estimated $14.3M sold.

Based on aggregated 13F filings for Q4 2017.